Sitemap

• About Ceva
  • Ceva Group
  • Ethics and Compliance
  • Our Commitment
  • Our Purpose
• Accessibility
• bloc_samples
• Careers
  • Careers at Ceva
• Ceva in the USA
  • Driving Innovation
  • History in the USA
  • Our Locations
  • Production
• Contact us
• Legal notice
• Our Portfolio
  • Companion Animals
    • Calming and Wellness
    • Cardiology
    • Dermatology
    • Internal Medicine
    • Parasitology
• Our Stories
  • Featured Stories
    • Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health
    • Ceva Animal Health and WVA Celebrate Global Veterinary Excellence during the 2025 AMVA conference
    • Ceva Animal Health inaugurates Biogenovac
    • Ceva Animal Health renews its shareholding structure with all its long-standing partners and opens its capital to Mérieux Institute and ARCHIMED to...
    • Ceva Animal Health unveils new global headquarters: A strategic step forward for future growth
    • Ceva joins the International Egg Foundation Partnership Programme
    • Ceva Names New SVP for North America
    • Collaborative effort to strengthen Singapore’s preparedness against avian influenza
    • ILRI and Ceva sign a memorandum of understanding strengthening public-private partnership to improve animal health
    • World-first koala chlamydia vaccine approved- a project supported by Ceva Wildlife Research Fund
  • Press Releases
    • CARDALIS® Receives U.S. Approval
    • Ceva Animal Health Acquires Sogeval
    • Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health
    • Ceva Animal Health inaugurates Biogenovac, a state-of-the-art Genomics Laboratory to Create Tomorrow’s Vaccines and Prevent Future Health Crises
    • Ceva Animal Health Leases Space in Hunt Midwest SubTropolis
    • Ceva Animal Health renews its shareholding structure with all its long-standing partners and opens its capital to Mérieux Institute and ARCHIMED to...
    • Ceva Animal Health Unveils New Global Headquarters: A Strategic Step Forward For Future Growth
    • Ceva Biomune Celebrates Completion of $10MM Expansion in Lenexa
    • Ceva Biomune is again expanding facilities to meet demand for its vaccine products.
    • Ceva opens new production facility in Lenexa, Kansas
    • Ceva receives US patent for innovative delivery system of treating poultry hatchlings through gel application
    • Collaborative effort to strengthen Singapore’s preparedness against avian influenza
    • PANOQUELL®-CA1 (fuzapladib sodium for injection) is now available in the U.S.
    • Predators vs. Farmers: Ceva Wildlife Research Funds finance a groundbreaking solution in Botswana
    • Program Receives Quality Recognition
    • Spoil Your Pets This Holiday Season with Douxo Spa
    • USA: CEVA Acquires Summit VetPharm, LLC
• Product Support
• Privacy policy
• Privacy Policy Contact form
• Alert System
• T&C of Purchase
• T&C of Sales
• Terms of Use